Switching of the Microglial Activation Phenotype Is a Possible Treatment for Depression Disorder
Major depressive disorder (MDD) is a common emotional cognitive disorder that seriously affects people’s physical and mental health and their quality of life. Due to its clinical and etiological heterogeneity, the molecular mechanisms underpinning MDD are complex and they are not fully understood. I...
Main Authors: | Lijuan Zhang, Jinqiang Zhang, Zili You |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fncel.2018.00306/full |
Similar Items
-
Ginsenoside Rb1 induces a pro-neurogenic microglial phenotype via PPARγ activation in male mice exposed to chronic mild stress
by: Lijuan Zhang, et al.
Published: (2021-08-01) -
Microglia and Macrophages in Neuroprotection, Neurogenesis, and Emerging Therapies for Stroke
by: Susanna R. Var, et al.
Published: (2021-12-01) -
Theaflavins Improve Memory Impairment and Depression-Like Behavior by Regulating Microglial Activation
by: Yasuhisa Ano, et al.
Published: (2019-01-01) -
Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder
by: Reza Rahimian, et al.
Published: (2022-06-01) -
Taking the perspective that a depressive state reflects inflammation: implications for the use of antidepressants
by: Jill Leslie Littrell
Published: (2012-08-01)